Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema

Launched by SULTAN ABDULHAMID HAN TRAINING AND RESEARCH HOSPITAL, ISTANBUL, TURKEY · Aug 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the connection between lymphedema—a condition that can cause swelling in the arms after breast cancer treatment—and myofascial pain syndrome, which is a type of pain that can occur in muscles and connective tissues. Researchers want to find out if the severity of lymphedema affects how often patients experience myofascial pain, how pain is felt in different areas, and how these issues impact daily activities and quality of life for women who have had breast cancer.

To participate in the study, women aged 18 to 75 who have been treated for breast cancer (such as through surgery or radiation) are eligible, provided they agree to take part in the research. However, women who currently have infections or other serious health issues, or who have bilateral breast cancer (cancer in both breasts), cannot join. If chosen to participate, individuals will undergo assessments to help understand the relationship between these conditions and how they affect patients' lives. This study aims to improve the care and support for women facing these challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria :
• • Breast cancer patients aged between 18-75 who had undergone the treatments as mastectomy, breast conserving surgery, lymph node dissection, sentinele lymph node biopsy or radiotherapy providing a written consent to participate in the study
• Exclusion Criteria :
• • Patients who do not agree to participate the study
• • Patients who had signs of active infection as lymphangitis, cellulitis, fungus
• • Bilateral breast cancer patients
• • Uncontrolled Psychiatric illness